Literature DB >> 10321207

Critical design errors in maxillary subperiosteal implants.

L I Linkow1, R Ghalili.   

Abstract

A maxillary full arch subperiosteal implant consists of a metallic framework that rests closely on the atrophied residual ridge beneath the mucoperiosteum and offers support for a dental prosthesis by means of posts or bars with O-ring protrusions or internal clip attachments. The maxillary subperiosteal implant is indicated for those patients presenting with advanced atrophy of the maxilla leaving the patient with three existing stable dense bony areas (the anterior nasal spine, the canine eminences, and the palatal surface of the existing crest) for its support. Over 300 cases with up to 12 years in function are presented. The importance of the basic anatomic and physiologic background required to optimize results are emphasized. The first 600+ subperiosteal implant cases that were placed prior to 1985 showed considerably lower success rates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10321207     DOI: 10.1563/1548-1336(1998)024<0198:CDEIMS>2.3.CO;2

Source DB:  PubMed          Journal:  J Oral Implantol        ISSN: 0160-6972            Impact factor:   1.779


  3 in total

1.  Custom-made 3D printed subperiosteal titanium implants for the prosthetic restoration of the atrophic posterior mandible of elderly patients: a case series.

Authors:  Carlo Mangano; Andrea Bianchi; Francesco Guido Mangano; Jessica Dana; Marco Colombo; Ivan Solop; Oleg Admakin
Journal:  3D Print Med       Date:  2020-01-08

2.  Squamous cell carcinoma around a subperiosteal implant in the maxilla and the association of chronic mechanical irritation and peri-implantitis: a case report.

Authors:  Takuma Watanabe; Dai Kawahara; Ryo Inoue; Tomoki Kato; Noboru Ishihara; Hidemichi Kamiya; Kazuhisa Bessho
Journal:  Int J Implant Dent       Date:  2022-03-02

3.  Custom-Made Direct Metal Laser Sintering Titanium Subperiosteal Implants: A Retrospective Clinical Study on 70 Patients.

Authors:  Mauro Cerea; Giorgio Andrea Dolcini
Journal:  Biomed Res Int       Date:  2018-05-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.